SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 151 filers reported holding SAGE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $56,000 | -27.3% | 771 | +40.2% | 0.00% | -100.0% |
Q3 2019 | $77,000 | -78.1% | 550 | -71.4% | 0.00% | -66.7% |
Q2 2019 | $351,000 | +457.1% | 1,922 | +380.5% | 0.00% | – |
Q1 2019 | $63,000 | +96.9% | 400 | +19.8% | 0.00% | – |
Q4 2018 | $32,000 | -60.5% | 334 | -41.2% | 0.00% | -100.0% |
Q3 2018 | $81,000 | +11.0% | 568 | +24.0% | 0.00% | 0.0% |
Q2 2018 | $73,000 | 0.0% | 458 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $73,000 | +15.9% | 458 | +19.9% | 0.00% | 0.0% |
Q4 2017 | $63,000 | +6200.0% | 382 | +2022.2% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 18 | +63.6% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | – | 11 | -31.2% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 16 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | -50.0% | 16 | -52.9% | 0.00% | – |
Q4 2015 | $2,000 | +100.0% | 34 | +78.9% | 0.00% | – |
Q3 2015 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q2 2015 | $1,000 | – | 19 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
Diametric Capital, LP | 19,393 | $626,000 | 0.46% |